An in-depth look to THIOGENESIS THERAPEUTICS CORP operating, investing, and financing activities

TTI free cash flow for Q2 24 is -551.12 k CAD. For 2023, TTI free cash flow was -3.25 M CAD and operating cash flow was -3.25 M CAD.